Fig 1: IL-24 protein protected mice from liver damage in the model of TAA-induced acute liver injury. Mouse IL-24 protein or PBS was intraperitoneally injected into mice 24 h before TAA treatment and 24 h and 48 h after TAA treatment (n = 5 each group). All mice were sacrificed 72 h after TAA treatment. (a) H&E stain was used to analyze the necrosis area. The TAA+IL-24 group had milder damage compared to that of the TAA-alone group. Original magnification: 200 × . (b-d) Immunohistochemistry was used to analyze expression level of IL-24, IL-20, and TGF-β by AEC chromogen stain (red), and the nuclei were counterstained with hematoxylin (blue). Original magnification: 200 × . (e) The mRNA transcripts of Il24, Il20, Tnfa, Tgfb, Ly6c, Cxcl1, Cxcl3, Sod, Gpx1, and Bax/Bcl2 were analyzed using real-time PCR with specific primers. Gapdh was used as an internal control. One-way ANOVA, * p< 0•05, ** p< 0•01, *** p< 0•001, **** p< 0•0001 compared with TAA+PBS group. Data are means ± SEM. (f) TUNEL assay was used to analyze the apoptotic cells (green) in the liver. Nuclei were stained with DAPI (blue). Original magnification: 100 × . (g) AML12 hepatocytes cell line were treated with deionized water (control) or TAA (100 mM) or TAA+IL-24 (400 ng/ml) for 24 h. Immunofluorescence was used to analyze level of the apoptotic marker-cleaved-caspase 3 (red). Nuclei were stained with DAPI (blue). Original magnification: 200 × . (h) The activity of catalase in the liver was also measured. One-way ANOVA, p = 0•0103. * p< 0•05 compared with TAA+PBS group. The experiments in a-h were repeated three times independently with similar results, and the data of one representative experiment was shown.
Fig 2: IL-24 inhibited gene expression of α-SMA in primary HSCs. Primary HSCs were isolated from wild-type mice for cell culture. The mRNA was isolated on day 1, day 3, day 5, and day 7. (a) Real-time PCR was conducted to analyze the gene expression of the quiescent HSCs marker – Gfap, the activated HSCs marker – α-SMA (Acta2), and alpha-1 type I collagen (Col1a1). Gapdh was used as an internal control. Two-tailed unpaired t-test, * p< 0•05, ** p< 0•01, *** p< 0•001, **** p< 0•0001. Data are means ± SEM. (b) The gene expression of Il24 and Il20 was analyzed by real-time PCR with specific primers. Two-tailed unpaired t-test, * p< 0•05 and ** p< 0•01. Data are means ± SEM. During the activation of HSCs, the gene expression of Il24 declined, while the expression of Il20 was gradually increased. (c) Primary hepatic stellate cells were isolated from mice and were immediately treated with PBS or IL-24 or IL-20 protein. Immunofluorescence was used to determine the protein expression of α-SMA (red) on day 3. Nuclei were stained with DAPI (blue). Original magnification: 200 × . (d) Primary hepatic stellate cells were isolated from mice and were immediately treated with PBS or IL-24 protein. Real-time PCR was applied to analyze the mRNA transcript of Acta2 and Tgfb on day 7. Gapdh was used as an internal control. Data are means ± SEM. Two-tailed unpaired t-test, * p< 0•05 and ** p< 0•01 compared with PBS group. Data are means ± SEM. (e) MTT assay showed the proliferation of the activated HSC at 24, 48 and 72 h. The percentage of cell viability was calculated. Two-tailed unpaired t-test, **** p < 0•0001 compared with PBS group. Data are means ± SEM. The experiments in a-e were repeated three times independently with similar results, and the data of one representative experiment was shown.
Fig 3: Intracellular IL-24 localizes to the inner mitochondrial membrane and is necessary and sufficient for IL-10 production by Th17 cells. (a) Naive T cells from Il24+/+ wild-type or Il24-/- mice were cultured in Th17 differentiation conditions for 3 d. Th17 cells were nucleofected with pIRES-eGFP, pIRES-eGFP-IL-24, or pIRES-eGFP-IL-24t on day 1 and analyzed for intracellular IL-10 on day 3 with representative FACS plots (left, pregated for viable CD4+ GFP+ cells) and summary of four independent experiments (mean ± SEM) normalized to wild type (right). Relative fraction indicates IL-10+ frequency (among CD4+ cells) for the respective nucleofection, divided by the corresponding IL-10+ frequency of the Il24+/+ pIRES-eGFP nucleofected (control) cells for each experiment. Asterisks indicate significance level of Dunnett’s multiple comparison test after one-way ANOVA (*, P < 0.05). (b) Naive T cells from wild-type mice were cultured in Th17 differentiation conditions. On day 2 of differentiation, cells were nucleofected with mRuby2-N1-IL-24t (top row) or mRuby2-N1-IFN-?t (bottom row) and analyzed for intracellular cytokine distribution by confocal microscopy. Mitochondria were marked with Mitotracker. Representative microphotographs; scale bar, 2 µm (left). Quantification of the cytokine signal in the mitochondrial compartment (right) from three independent experiments (mean ± SEM). Asterisk indicates statistical significance of a two-tailed t test. (c) Naive wild-type or Il24-/- T cells mice were differentiated into Th17 cells. On day 3, mitochondrial (Mito.) and nuclear (Nucl.) fractions were isolated and probed for STAT3. Lamin B1 and NDUFA9 were used as loading controls for nuclear and mitochondrial fractions, respectively (left). Densitometric quantification (right) of three independent experiments (mean ± SEM). Asterisk indicates statistical significance of a two-tailed t test. (d) Grim19 interacts with STAT3 in an IL-24–dependent manner. Naive T cells from wild-type or Il24-/- mice were differentiated into Th17 cells. On day 3, cells were transferred into medium containing IL-2 (2 ng/ml). After 24 h, mitochondrial fractions were isolated, solubilized, immunoprecipitated with anti-Grim19 monoclonal antibody (Grim19IP), and probed for the amount of pulled STAT3 by Western blot. Solubilized mitochondrial fraction (input) was used as a control for coimmunoprecipitation. Representative Western blots from three independent experiments. (e) Loss of STAT3 from nuclear compartment. Naive T cells from wild-type or Il24-/- mice were cultured in Th17 differentiation conditions for 3 d. After 3 d, cells were transferred into IL-2 medium (2 ng/ml) and analyzed for STAT3 in the nuclear compartment at baseline and after 6, 12, and 24 h. Representative Western blots (left) with normalized densitometry data (right) quantified from three to six independent experiments (mean ± SEM). Asterisks indicate significance level of Sidak’s multiple comparison test following two-way ANOVA (*, P < 0.05). Source data are available for this figure: SourceData F6.
Fig 4: IL-24 segregates with the Th17-associated portfolio of cytokines. (a) Naive T cells were differentiated into Th0, Th1, or Th17 cells (TGF-ß plus IL-6). Their transcriptome was assessed by microarray analysis (Heinemann et al., 2014). (b and c) The indicated T cell subsets were differentiated for 3 d from naive T cells in vitro, followed by analysis of RNA and culture supernatants by RT-qPCR and ELISA, respectively. Both readouts show summarized data (mean ± SEM) from two independent experiments. Asterisks indicate significance level after one-way ANOVA followed by Sidak’s multiple comparison test (multiplicity-adjusted P values: ****, P < 0.0001; ***, P < 0.001; **, P < 0.01), with asterisks on top relating to results from tests against Th0 and black lines indicating individual results from tests against Th17. (b) Results from RT-qPCR using TaqMan assays, showing Il24 normalized to Actb expression with log-transformed values relative to Th0. (c) Secretion of IL-24 into the supernatant as assessed by ELISA.
Fig 5: IL-24 regulates IL-10 in Th17 cells in a cell-autonomous manner in vivo. (a and b) MBMC mice were generated with a 1:1 chimerism of congenically marked CD45.1 wild-type (green gates) and Il24-/- CD45.2 (red gates) bone marrow. (a) After induction of EAE, T cells were isolated at peak disease from the spleen (representative FACS plots, pregated for viable CD4+ cells) and the CNS (Fig. S2 a) and assessed for the production of cytokines by intracellular cytokine staining after ex vivo PMA/ionomycin stimulation. (b) Ratios of cytokine-positive fractions in IL-24–deficient vs. IL-24–sufficient T cells, summarized (mean ± SEM) from two independent experiments. (c and d) Mixed adoptive transfer EAE. Th17 cells were generated from naive wild-type 2D2 T cells (that were genetically labeled with mitoDendra2, a green fluorescent protein) or unlabeled naive IL-24–deficient 2D2 T cells. For cytokine production of these Th17 cells before transfer, see Fig. S2 b. (c) After cotransfer of wild-type (green gates) and IL-24–deficient 2D2 Th17 cells (red gates) into Rag1-/- mice, T cells were reisolated from the spleen (pregated on viable CD4+ cells) and the CNS (Fig. S2 c) at the peak of EAE and subjected to intracellular cytokine staining. (d) Ratios of cytokine-positive fractions in IL-24–deficient vs. IL-24–sufficient 2D2 Th17 cells (seven biological replicates, mean ± SEM) after reisolation from host mice. In panels b and d, asterisks indicate significance level of one-sample t tests against a value of 1 (i.e., significantly different from an equal production of the respective cytokine in both compartments; ***, P < 0.001; *, P < 0.05).
Supplier Page from R&D Systems, a Bio-Techne Brand for IL-24 Antibody
Available conjugates: Available conjugates: UnconjugatedSpecificity: Detects mouse IL-24 in direct ELISAs and Western blots. In direct ELISAs, less than 5% cross-reactivity with recombinant human IL-24 is observed.Sizes Available: 100 ug (also 25 ug)